bobby
Neuland Laboratories Stock Turned ₹1 Lakh: Neuland Laboratories shares have created substantial wealth for long-term investors, with the pharmaceutical stock delivering exceptional returns over the past two decades.
An investment of ₹1 lakh made around 20 years ago would have grown to approximately ₹2.15 crore, based on the share-price figures provided. Veteran investor Vijay Kedia also has exposure to the company through Kedia Securities Private Limited.
The stock recently touched a new 52-week high, adding to investor interest in Neuland Laboratories.
💰 ₹1 Lakh in Neuland Laboratories Became More Than ₹2 Crore
Neuland Laboratories has delivered extraordinary returns to investors who remained invested in the stock over the long term.
The company’s shares were trading at ₹109.25 on September 8, 2006. Nearly two decades later, Neuland Laboratories shares closed at ₹23,536.20 on the BSE on September 11, 2026.
Based on these prices, the stock has gained approximately 21,346% over the period.
That means an investor who put ₹1 lakh into Neuland Laboratories shares in September 2006 and continued holding the investment would have seen its value grow to approximately ₹2.15 crore, excluding the impact of taxes, transaction costs and any other corporate actions that may affect the calculation.
The remarkable rise highlights the wealth-creation potential that some businesses can deliver over very long holding periods. However, historical returns do not guarantee similar performance in the future.
📈 Neuland Laboratories Shares Jump 1,226% in 5 Years
The stock’s performance has also been impressive over shorter periods.
Neuland Laboratories shares were trading at ₹1,766.80 on September 9, 2021. The stock closed at ₹23,536.20 on September 11, 2026.
This translates into an increase of approximately 1,226% in five years based on the supplied prices.
The pharmaceutical stock has also recorded strong gains across several other time periods:
- 5-year return: approximately 1,226%
- 4-year return: approximately 1,850%
- 3-year return: approximately 535%
- 6-month return: approximately 83%
The figures underline the scale of the rally Neuland Laboratories shares have experienced in recent years.
🚀 Neuland Laboratories Hits New 52-Week High
Neuland Laboratories shares recently touched a fresh 52-week high of ₹24,235.05.
The stock’s 52-week low stands at ₹11,500, showing the significant movement in its market price over the past year.
Against its 52-week low, the stock has more than doubled at its recent peak.
Investors should remember, however, that a sharp rise in share price can also lead to increased volatility. Past price appreciation alone should not be considered a reason to buy or sell a stock.
👨💼 Vijay Kedia Holds 1.01% Stake in Neuland Laboratories
Another factor attracting market attention is the presence of veteran stock-market investor Vijay Kedia among the company’s shareholders.
Kedia has exposure to Neuland Laboratories through his investment vehicle, Kedia Securities Private Limited.
According to the supplied shareholding figures, Kedia Securities Private Limited holds 130,000 shares of Neuland Laboratories, representing approximately a 1.01% stake in the company.
Vijay Kedia is widely followed by Indian retail investors, meaning changes in his publicly disclosed portfolio often attract considerable market interest.
However, an investment by a prominent investor should not by itself be treated as a recommendation to buy a stock.
💼 Mukul Agrawal Also Holds a Stake
Vijay Kedia isn’t the only well-known investor with exposure to Neuland Laboratories.
Prominent investor Mukul Mahavir Agrawal holds 400,000 shares of the pharmaceutical company, according to the supplied data.
His holding represents approximately 3.12% of the company.
The presence of prominent investors can draw additional attention to a stock, but retail investors should evaluate a company’s fundamentals, valuation, earnings outlook and risks independently before making investment decisions.
🔍 Why Is Neuland Laboratories Stock in Focus?
Neuland Laboratories has attracted attention primarily because of its exceptional historical share-price performance.
A rise from ₹109.25 in September 2006 to ₹23,536.20 in September 2026 represents substantial long-term wealth creation for investors who remained invested throughout the period.
More recently, the stock’s approximately 1,226% five-year gain, its strong six-month performance and its new 52-week high have kept it in focus.
The disclosed holdings of investors such as Vijay Kedia and Mukul Agrawal add another layer of market interest.
⚠️ What Should Investors Consider?
Although Neuland Laboratories’ historical returns are impressive, investors should avoid making decisions based solely on past stock performance or the portfolios of prominent investors.
Before investing, factors such as the company’s revenue growth, profitability, margins, debt, cash flow, competitive position, valuations and future business prospects should be examined.
A stock that has generated exceptional returns historically can still experience significant corrections or periods of weak performance.
FAQs About Neuland Laboratories Shares
1. How much would ₹1 lakh invested in Neuland Laboratories 20 years ago be worth?
Based on the supplied share prices of ₹109.25 in September 2006 and ₹23,536.20 in September 2026, an investment of ₹1 lakh would have grown to approximately ₹2.15 crore, subject to assumptions regarding corporate actions, taxes and transaction costs.
2. How much has Neuland Laboratories stock risen in 20 years?
Based on the supplied figures, Neuland Laboratories shares have gained approximately 21,346% over the 20-year period.
3. What is Neuland Laboratories’ 5-year return?
The stock rose from ₹1,766.80 in September 2021 to ₹23,536.20 in September 2026, representing an increase of approximately 1,226%.
4. Does Vijay Kedia own Neuland Laboratories shares?
According to the supplied shareholding data, Kedia Securities Private Limited holds 130,000 shares, equivalent to approximately 1.01% of Neuland Laboratories.
5. Does Mukul Agrawal hold Neuland Laboratories shares?
According to the supplied figures, Mukul Mahavir Agrawal holds 400,000 shares, representing approximately a 3.12% stake in the company.
6. What is the 52-week high of Neuland Laboratories shares?
According to the supplied market data, Neuland Laboratories’ 52-week high is ₹24,235.05, while its 52-week low is ₹11,500.
Disclaimer
This article is for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or sell any security. Stock-market investments are subject to market risks. Historical returns do not guarantee future performance. Investors should conduct independent research and consult a qualified financial adviser before making investment decisions.
